May 22, 2025

AI, IP, and the Future of Litigation Funding

Subscribe to Our Newsletter

Newsletter


Kevin Skrzysowski

|

May 22, 2025

AI, IP, and the Future of Litigation Funding. I had an insightful conversation with my latest guest and colleague, Bryce Barcelo, Director of IP Strategy at Certum Group and a professor of patent litigation at the University of Houston Law Center. In this episode, we dive into how AI is (and isn’t) being used in legal practice, the growing legal challenges around data and copyright, the explosion of IP litigation funding, and what leadership changes at the USPTO could mean for patent holders.


This transcript has been lightly edited for grammar and clarity.

Kevin Skrzysowski:

Welcome to the 33rd episode of Certum Group’s podcast, Alternative Litigation Strategies. I’m your host, Kevin Skrzysowski, a director here at Certum Group, where we provide the nation’s largest platform of litigation risk management solutions. I’m very pleased to be joined today by a colleague of mine for the first time in three years, Bryce Barcelo. Bryce is the Director of IP Strategy at Certum Group, where he leads our IP licensing, funding, insurance litigation, and acquisition strategies. He’s also a professor of patent litigation at the Houston Law Center, so he’s a great person to speak with about today’s topics, which include artificial intelligence and intellectual property. About two sessions ago, I had a guest on to talk about AI’s impact on law practice and workplace efficiency. Today, I want to expand on that and ask you, Bryce, what role do you see AI playing in patent litigation, and are there any tools out there you think will really move the market?

Bryce Barcelo:

Yeah, sure thing. AI is a buzzword that has a lot of different meanings right now. When people hear “AI,” they often imagine a system that can take over your job. We’re nowhere near that. In fact, I don’t think we’ll get there anytime soon. That said, there are aspects of AI I’ve already started incorporating into my workflow. I’ve talked with others who are doing the same—or who’ve tried things that didn’t work. The key is to be critical of the tools you’re using. It doesn’t help to jump into ChatGPT and expect it to do your whole job. I was on a plane recently next to a surgeon who was copying and pasting surgical plans into ChatGPT, and I just thought, “I really hope he’s reading those before following the advice.” For legal professionals, one tool I’ve used is Westlaw’s CoCounsel and research assistant AI. It’s essentially a smarter search engine, which is what most AI amounts to right now. Think of it like a Google upgrade – a more contextual, legally-fluent search tool that helps you find deeper, faster insights.

Kevin Skrzysowski:

Is it like Google on steroids? I heard someone say if you’re still using Google and not ChatGPT, you’re basically an idiot. Do you think that’s true?

Bryce Barcelo:

Not at all. That’s a hot take, but it misses the point. ChatGPT and most generative AIs aren’t always up-to-date. Google is. For breaking news or recent legal decisions, Google still wins. AI tools are helpful for diving deep into subjects that are already well-documented, but for emerging issues, you’ll still want traditional search tools. Some platforms like Perplexity are starting to bridge that gap by pulling in live sources, but we’re not there yet for all use cases. Search isn’t dead – AI just gives you another lens when you’re trying to think critically or generate ideas.

Kevin Skrzysowski:

That makes sense. What about the legal implications of AI development, especially with copyright? I know the New York Times recently filed against OpenAI, and that case survived a motion to dismiss. What’s your take on the legality of AI’s data ingestion?

Bryce Barcelo:

Great question, and one I’ve spent time thinking about. I try to ask: what if a human was doing what AI does? If a person read thousands of books and then created a website that answered questions based on that knowledge – without directly quoting – most courts would be fine with that. But AI doesn’t operate like a human. It vacuums up data, including tons of copyrighted material, without the same discretion. We’ve seen this with leaks tied to Meta and OpenAI. The data isn’t always freely available or ethically sourced. Yet to train these models effectively, companies need massive datasets. That creates tension between innovation and copyright protection. If a person did this with 1,000 books, it’d be one thing. But when an AI model does it at scale, often without compensation to creators, we’re in murky territory. That’s a big problem for IP law.

Kevin Skrzysowski:

Exactly. The same conclusion we reached in a previous episode. It augments human work, but doesn’t replace the human brain. Especially in law, with ethical responsibilities and malpractice risk, a human must review anything AI produces.

Bryce Barcelo:

Exactly. Just look at that case involving Mike Lindell’s lawyers. They used AI to help draft a legal brief, and the court found over 30 fabricated citations. There were fake cases – just made up. Judges are cracking down, and rightfully so. You can’t rely on AI alone, especially when the stakes are high. There need to be consequences for that kind of misuse.

Kevin Skrzysowski:

Absolutely. Let’s pivot to something you’ve been spearheading here: IP funding. You’ve led our IP practice for over a year. What are you seeing in the funding space? What’s trending, and what’s working?

Bryce Barcelo:

IP funding is absolutely booming. A recent report confirmed that there’s strong momentum and seemingly no ceiling yet. The volume of opportunities is growing, but so are the challenges. You need a strong case on the merits – something that a lot of patent owners underestimate. Patent litigation is complex and costly. I’m seeing more people enter the space who haven’t really assessed the strength of their claims at the level these cases require. That said, IP funding is crucial for giving inventors and companies their day in court. We’re enabling access to justice, but we also have to make sure we’re not steering people toward litigation when it’s not a viable option. It’s a balancing act, but an exciting time for innovation.

Kevin Skrzysowski:

Before joining Certum, you were a litigator at one of the top boutique firms, often defending smaller businesses against corporate giants. You recently spoke to Bloomberg Law about John Squire’s nomination as USPTO Director. Given his background in funding, how do you think his leadership will impact the industry?

Bryce Barcelo:

It’s a positive development. For the first time, we have someone coming into that role who understands litigation funding. He knows this isn’t a shadowy or dangerous industry – it’s about giving legitimate patent holders a chance to enforce their rights. Acting Director Kathi Vidal had already pushed the PTO toward supporting patent owners more strongly, and I think Squire will continue that trend. With his litigation funding experience, he understands the burden and cost of enforcement. That kind of perspective will be a game-changer for leveling the playing field. Too often, inventors get pushed out by companies that infringe with impunity. Squire can help shift the balance back toward fairness.

Kevin Skrzysowski:

We’ve seen that with our clients too. Many are brilliant engineers or solo inventors, and their ideas are being taken by larger players. It’s rewarding to help them stand their ground and protect what they’ve built.

Bryce Barcelo:

Absolutely.

Kevin Skrzysowski:

Before we wrap, I want to ask you a final question I often pose to my guests. As a law professor, what advice would you give to undergraduates or law students who are considering a legal career, especially in IP?

Bryce Barcelo:

It’s a very relevant question. I actually have a niece going through this right now. She just finished undergrad and is applying to law school. My first advice is: don’t assume you know what being a lawyer means. It’s not just what you see on TV. Law is broad, and each practice area is different. Students need to educate themselves, especially on the financial investment. Law school is expensive, and competition is fierce. Talk to practicing lawyers. Learn what their day-to-day is like. That’s important before even taking the LSAT. For law students who already made the leap – my advice is to stay flexible. You may start law school thinking you’ll do one thing, and end up somewhere totally different. I was an aerospace engineer before law school, and I thought I’d go into patent prosecution. I took all the right classes, interned at prosecution firms, and genuinely liked it. But a chance encounter led me into litigation, and I stayed for 10 years. You never know what will spark your passion. Stay curious. Get to know your professors. Use them as resources. I tell my students: the relationship doesn’t end with the class. Email me. Connect on LinkedIn. Keep asking questions as your career unfolds.

Kevin Skrzysowski:

That’s one of the most thoughtful answers I’ve received. I really appreciate you sharing your story. On a related note, my last guest, Will Marra at Penn Law, had this great idea to have top-performing students from his litigation funding class join the podcast. I’d love to do the same with your students. Maybe host a roundtable?

Bryce Barcelo:

That’s a great idea. I’d love that. It would be excellent exposure for them. I’ve given out firm swag as class rewards in the past, but this would be next level.

Kevin Skrzysowski:

Let’s do it. It would make for an engaging and timely conversation. Finally, before we close out—how can listeners reach you if they want to continue the discussion?

Bryce Barcelo:

The best way is email: bbarcelo@certumgroup.com. I’m an inbox zero person, so I will see it. For urgent matters, I can also be reached by phone at 713-398-4159.

Kevin Skrzysowski:

Thanks again, Bryce. It’s been a pleasure having you on the program. For anyone looking to connect with me, I’m at kevins@certumgroup.com or 216-570-9370. You can listen to this and all of our episodes on Apple, Spotify, Stitcher, and your favorite platforms. Until next time – thanks for tuning in.

Bryce Barcelo:

Thanks again, Kevin.

Certum Group Can Help

Get in touch to start discussing options.

Recent Content

By Patrick Dempsey • October 13, 2026
This is the fourth post in Certum Group's seven-part series bringing our Trade Secret Litigation Playbook to the blog. It draws on Part IV of the Playbook, What Your Case Is Worth. Read or download the full Playbook here . Ask a business owner what a trade secret case is worth, and the first instinct is almost always the same: what did we lose? It is the intuitive measure, and it is usually the smallest one on the table. Trade secret law rewards claim holders who think about damages more expansively than "our lost sales," and the gap between the intuitive number and the recoverable number is often enormous. There are four measures worth understanding, and lost profits is only the first. Lost profits: what you would have earned The revenue you would have earned absent the misappropriation — contracts you would have signed, renewals you would have held, pricing power you could have sustained. Lost profits require you to prove causation between the taking and the foregone revenue, which is where most of the work goes. It is a real number, but it is anchored to your own historical performance, and that ceiling is frequently lower than what the case is actually worth. Unjust enrichment: what the defendant gained This is usually the largest measure, and by a wide margin. Unjust enrichment captures everything the defendant gained by taking the shortcut: the R&D and engineering it avoided, the head-start value of reaching the market faster than an independent developer could have, the savings and margins it captured, and — in the strongest cases — disgorgement of the revenue its product earned because it was built on your secret. In software, manufacturing, and pharmaceutical cases, the avoided-time-to-market term alone can dwarf your lost profits, because it measures the defendant's entire economic benefit rather than your specific loss. Reasonable royalty: the floor An objective measure grounded in what the defendant would have paid to license the secret in an arm's-length deal. It is typically the smallest of the three, but it functions as a floor when lost profits are speculative and unjust enrichment is contested. Sophisticated claim holders do not treat it as a fallback; they treat it as an independent anchor that constrains how small the number can reasonably be. Exemplary damages and fees: what willful conduct adds If the misappropriation was willful and malicious, the DTSA and most state statutes allow enhanced damages of up to twice the compensatory award, plus attorney's fees. 1 Willfulness is not a rhetorical flourish; it is a doubling, sometimes a tripling, of the core recovery. And the evidence that establishes it — an internal email, a board slide, a pattern of ignored warnings — is exactly the kind of material that discovery tends to surface. That is why intent belongs at the center of the case from day one. The Versata signal If you want a live illustration of how large the gap can be, look at the Federal Circuit's 2026 decision in Versata Software v. Ford. The trial court had tried to cap Versata's trade secret damages at a licensing-based model — essentially, what Ford would have paid — and zeroed out the rest as an undeserved "windfall." The Federal Circuit disagreed, holding that the DTSA's text expressly allows recovery of the unjust enrichment the defendant captured, even when that figure is far larger than any license fee. The message to corporate defendants is blunt: if you misappropriate rather than license, you assume the risk that the damages will dwarf what you could have paid. The message to claim holders is just as clear — the ceiling on your case is often much higher than your accountant's first estimate. Why this matters before you file Claim holders who engage a damages expert early consistently do better — not because the expert changes the facts, but because an early damages view changes three downstream decisions. It changes which counsel you hire, because the firms built for a $50 million case are different from the firms built for a $5 million case. It changes your fee structure, because a firm weighing a contingency needs a damages view to price it. And it changes settlement posture, because a plaintiff who can articulate a well-supported range anchors the negotiation, while one who cannot is negotiating against the defendant's number. The defendant almost always knows what you might get at trial. The only question is whether you do. Go deeper with the Playbook. This post covers one piece of a much larger picture. For the full framework — what the law requires, what a strong pre-filing case looks like, how damages experts value these matters, how counsel fee structures change your economics, and how litigation finance fits in — read Certum Group's Trade Secret Litigation Playbook , our field guide for business owners and the counsel who advise them: certumgroup.com/the-trade-secret-playbook . And if you are evaluating a live dispute — or simply want to pressure-test what a matter is worth and how it might be funded — get in touch. A confidential conversation with Certum is free and carries no obligation, whether or not you ultimately seek funding. Reach us at certumgroup.com/contact-us . Sources 1. 18 U.S.C. Section 1836(b)(3)(B) (permitting recovery of unjust enrichment not addressed in computing actual loss); Section 1836(b)(3)(C)-(D) (exemplary damages up to twice the compensatory award, and attorney's fees, for willful and malicious misappropriation).
By Patrick Dempsey • September 29, 2026
This is the third post in Certum Group's seven-part series bringing our Trade Secret Litigation Playbook to the blog. It draws on Part III of the Playbook, Before You File. Read or download the full Playbook here . The call usually comes from a sales leader, a head of engineering, or a chief of staff, and it usually starts the same way: "We think someone took X, and we think they took it to Y." What happens in the next three days is disproportionately important. The most expensive mistake in trade secret practice is waiting — every week that passes lets the defendant commercialize your advantage, and worse, lets the evidence quietly disappear. Slack messages, badge records, and git histories often sit behind auto-delete settings as short as ninety days. So before you do anything else, move to preserve. Here is what good early triage looks like. Issue a litigation hold — in writing, within 24 hours A written instruction to preserve any document, chat, email, calendar, or file relating to the possible misappropriation, sent to the full legal, HR, IT, and leadership teams. It should be specific enough to be useful, broad enough to catch the unexpected, and documented enough that you can produce it later. This is the single most important thing you can do in the first day. Lock down forensic images — and don't let internal IT do it Laptops, phones, and company devices belonging to any suspected party should be forensically imaged by an outside forensics firm, not wiped or "checked" by internal IT. Chain of custody matters, and internal teams generally cannot testify to it at trial. The right instinct is to image broadly and review narrowly: you can always decline to look at a device you preserved, but you can never go back for one that was reissued, wiped, or sold. And don't forget the non-obvious sources — personal cloud drives, USB connection histories, printer spooler logs, and screen-capture utilities are often where the decisive evidence actually lives. Extend retention on cloud and platform logs Have IT extend retention on the relevant accounts and export the log data — access logs, download histories, egress traffic — before anything rolls off. The forensic story of who did what, when, and with which file is usually more persuasive to a judge than any human witness. A download at 11:47 p.m. the night before a resignation is powerful evidence because of what the timing means. Do not tip off the adversary Resist the urge to confront the suspected employee, their new employer, or their counsel. Confrontation at this stage tends to accelerate deletion and pull communications behind privilege claims. A carefully timed cease-and-desist letter, sent after preservation is secure, is a very different move — and a far more effective one. Investigate under privilege Any investigation you run should be conducted under attorney direction, so that the work product is privileged and your witness interviews do not become admissions used against you later. This is not about secrecy for its own sake. It is about making sure the investigation helps your case rather than becoming evidence in it. Consider — but do not rush — the early public filing Ex parte seizure orders, temporary restraining orders, and preliminary injunctions all have their place, and an early injunction can be the single most valuable outcome in the whole case. 1 But these motions require a level of evidentiary support you rarely have on day three. It is almost always better to spend a week building the record than to file fast and lose the first motion, which hands the defendant a narrative and hands you a hole to climb out of. The triage checklist If you want a single page to keep by the phone, it looks like this: litigation hold issued in writing within 24 hours; outside forensics firm retained and imaging scheduled; cloud and platform log retention extended; a list of suspected individuals plus their managers and peers; a list of the specific secrets that may have been taken; copies of every NDA, employment agreement, and IP assignment covering them; a review of the last 90 days of their calendar for unusual patterns; and outside trade secret counsel engaged under privilege. Do the first 72 hours well and you preserve every option that follows — injunction, damages, settlement leverage. Do them poorly and you may spend the next two years litigating around evidence you could have saved in an afternoon. If you are in the opening days of a matter and want a fast, confidential read on what to do now versus later, that is exactly the conversation we have most often. Go deeper with the Playbook. This post covers one piece of a much larger picture. For the full framework — what the law requires, what a strong pre-filing case looks like, how damages experts value these matters, how counsel fee structures change your economics, and how litigation finance fits in — read Certum Group's Trade Secret Litigation Playbook , our field guide for business owners and the counsel who advise them: certumgroup.com/the-trade-secret-playbook . And if you are evaluating a live dispute — or simply want to pressure-test what a matter is worth and how it might be funded — get in touch. A confidential conversation with Certum is free and carries no obligation, whether or not you ultimately seek funding. Reach us at certumgroup.com/contact-us . Sources 1. The ex parte seizure procedure is authorized by the Defend Trade Secrets Act, 18 U.S.C. Section 1836(b)(2), and is available only in extraordinary circumstances.
By Patrick Dempsey • September 15, 2026
This is the second post in Certum Group's seven-part series bringing our Trade Secret Litigation Playbook to the blog. It draws on Part II of the Playbook, Trade Secret Law in Plain English. Read or download the full Playbook here . Here is a statistic that surprises most executives: in federal trade secret cases that reach a verdict, plaintiffs win roughly 84% of the time. 1 That is dramatically better than the plaintiff win rate in commercial litigation generally. It does not mean every case is easy — the cases strong enough to reach a jury are a selected group — but it tells you something important about what happens when a well-built trade secret claim gets in front of a fact-finder: courts tend to enforce the rights the statute was designed to protect. So why do good claims still fail? Usually not at trial. They fail earlier, on assumptions the claim holder never stopped to test. In more than a decade of evaluating these matters, the same handful of misconceptions come up again and again. Here are six worth clearing up before they cost you a case. Myth 1: "It's only a trade secret if we stamped it CONFIDENTIAL." Marking helps, but it is not required. What matters is whether your overall secrecy program is reasonable under the circumstances — a holistic look at contractual, physical, and technical controls. A perfect stamp on an otherwise open system is worth less than a coherent program with a few gaps. Myth 2: "If part of it is public, none of it is protected." Courts routinely protect a combination of individually public facts when the particular combination delivers competitive advantage. The recipe can be assembled from ingredients anyone can buy. What you protect is the assembly. Myth 3: "Our employees signed NDAs, so we're covered." NDAs are a foundation, not a program. The full set of reasonable measures a serious claim holder is expected to have includes access controls, badging, egress monitoring, exit procedures, and technical segmentation. An NDA in the drawer and nothing behind it is exactly the gap a well-resourced defendant will press on first. Myth 4: "We didn't sue the last person who left, so it's too late now." Trade secret protection is evaluated case by case. Declining to act on one departure does not forfeit your rights as to the next one. Every matter stands on its own facts. Myth 5: "We're too small to enforce against a big company." This one gets the economics backwards. A well-funded claim against a large, solvent defendant is often easier to win — and easier to collect — than a disorganized claim against a small one. Resources can be added to a strong case; facts cannot be added to a weak one. The right capital partner exists precisely so that a smaller plaintiff can stand toe-to-toe with a much larger adversary and neutralize the outspend-them tactics that used to decide these fights. Myth 6: "It's just know-how — courts don't protect that." Courts protect integrated know-how constantly. The question is never whether know-how is capable of protection; it is whether you can identify it with enough particularity to describe what was taken. 2 That is the single most consequential early decision in the case, and it is the one most claim holders do not realize they are making when they plead "our proprietary software" instead of the specific, described combinations that actually give them an edge. The through-line Notice what these myths have in common: each one leads a claim holder to under-invest in a case that the numbers say is very winnable. The 84% figure is not a promise. It is an invitation to take the early work seriously — the secrecy program, the identification, the evidence — because that work is what turns a strong set of facts into a strong case. Get those right, and the law is on your side more often than in almost any other kind of commercial dispute. Go deeper with the Playbook. This post covers one piece of a much larger picture. For the full framework — what the law requires, what a strong pre-filing case looks like, how damages experts value these matters, how counsel fee structures change your economics, and how litigation finance fits in — read Certum Group's Trade Secret Litigation Playbook , our field guide for business owners and the counsel who advise them: certumgroup.com/the-trade-secret-playbook . And if you are evaluating a live dispute — or simply want to pressure-test what a matter is worth and how it might be funded — get in touch. A confidential conversation with Certum is free and carries no obligation, whether or not you ultimately seek funding. Reach us at certumgroup.com/contact-us . Sources 1. Stout, Trends in Trade Secret Litigation (2024), reporting an approximately 84% plaintiff-favorable outcome rate across 271 federal trade secret cases reaching a verdict since 2017. 2. Both the federal Defend Trade Secrets Act (18 U.S.C. Section 1836) and the state Uniform Trade Secrets Act define a trade secret as information that derives independent economic value from not being generally known or readily ascertainable, and that is the subject of reasonable measures to keep it secret.